Publication Name	World Journal of Gastroenterology
Manuscript ID	79388
Country	Switzerland

Received	2022-08-18 17:07
Peer-Review Started	2022-08-18 17:10
To Make the First Decision
Return for Revision	2022-09-08 06:54
Revised	2022-10-31 10:42
Second Decision	2022-11-16 03:16
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-11-16 19:29
Articles in Press	2022-11-16 19:29
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-11-13 20:58
Typeset the Manuscript	2022-12-21 00:00
Publish the Manuscript Online	2022-12-27 10:06

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Recent advances in the management of autoimmune pancreatitis in the era of artificial intelligence
Manuscript Source	Unsolicited Manuscript
All Author List	Sahar Mack, Yves Flattet, Philippe Bichard and Jean Louis Frossard
ORCID	Author(s) ORCID Number Sahar Mack http://orcid.org/0000-0002-6971-2992 Jean Louis Frossard http://orcid.org/0000-0002-6309-1603
Funding Agency and Grant Number
Corresponding Author	Jean Louis Frossard, MD, Associate Professor, Division of Gastroenterology, Department of Medical Specialties, University Hospital of Geneva, Rue Gabrielle-Perret-Gentil 4, Geneva 1205, Switzerland. jean-louis.frossard@hcuge.ch
Key Words	Autoimmune pancreatitis; Pancreatic ductal adenocarcinoma; Immunoglobulin G4-related disease; Prednisone; Rituximab; Artificial intelligence; Plasmablasts
Core Tip	The diagnosis of autoimmune pancreatitis (AIP) is challenging. Indeed, 60% and 78% of type 1 and type 2 AIP, respectively, are retrospectively evaluated on surgical specimens of resected pancreas for suspected cancer. Obtaining a definitive diagnosis can thus prove difficult, since endoscopic ultrasound fine-needle aspiration or biopsy of the pancreas are suboptimal. This paper focuses on recent innovations in the management of AIP using artificial intelligence, new serum markers, and new therapeutic approaches and outlines the current recommendations. Improved knowledge of AIP can reduce the recourse to surgery, although this requires collaboration between gastroenterologists, surgeons and radiologists.
Publish Date	2022-12-27 10:06
Citation	Mack S, Flattet Y, Bichard P, Frossard JL. Recent advances in the management of autoimmune pancreatitis in the era of artificial intelligence. World J Gastroenterol 2022; 28(48): 6867-6874
URL	https://www.wjgnet.com/1007-9327/full/v28/i48/6867.htm
DOI	https://dx.doi.org/10.3748/wjg.v28.i48.6867

Full Article (PDF)	WJG-28-6867.pdf
Full Article (Word)	WJG-28-6867.docx
Manuscript File	79388_Auto_Edited-LM.docx
Answering Reviewers	79388-Answering reviewers.pdf
Audio Core Tip	79388-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	79388-Conflict-of-interest statement.pdf
Copyright License Agreement	79388-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	79388-Language certificate.pdf
Peer-review Report	79388-Peer-review(s).pdf
Scientific Misconduct Check	79388-Bing-Wang JJ-2.png
Scientific Editor Work List	79388-Scientific editor work list.pdf